JP2020019813A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020019813A5 JP2020019813A5 JP2019186857A JP2019186857A JP2020019813A5 JP 2020019813 A5 JP2020019813 A5 JP 2020019813A5 JP 2019186857 A JP2019186857 A JP 2019186857A JP 2019186857 A JP2019186857 A JP 2019186857A JP 2020019813 A5 JP2020019813 A5 JP 2020019813A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- amino acid
- composition
- syndrome
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462043084P | 2014-08-28 | 2014-08-28 | |
| US62/043,084 | 2014-08-28 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017511190A Division JP6651506B2 (ja) | 2014-08-28 | 2015-08-28 | 補体関連障害を処置するための組成物、方法およびキット |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020207487A Division JP7275095B2 (ja) | 2014-08-28 | 2020-12-15 | 補体関連障害を処置するための組成物、方法およびキット |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020019813A JP2020019813A (ja) | 2020-02-06 |
| JP2020019813A5 true JP2020019813A5 (https=) | 2020-03-19 |
| JP6811821B2 JP6811821B2 (ja) | 2021-01-13 |
Family
ID=55400647
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017511190A Active JP6651506B2 (ja) | 2014-08-28 | 2015-08-28 | 補体関連障害を処置するための組成物、方法およびキット |
| JP2019186857A Active JP6811821B2 (ja) | 2014-08-28 | 2019-10-10 | 補体関連障害を処置するための組成物、方法およびキット |
| JP2020207487A Active JP7275095B2 (ja) | 2014-08-28 | 2020-12-15 | 補体関連障害を処置するための組成物、方法およびキット |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017511190A Active JP6651506B2 (ja) | 2014-08-28 | 2015-08-28 | 補体関連障害を処置するための組成物、方法およびキット |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020207487A Active JP7275095B2 (ja) | 2014-08-28 | 2020-12-15 | 補体関連障害を処置するための組成物、方法およびキット |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US10813977B2 (https=) |
| EP (2) | EP3892291A1 (https=) |
| JP (3) | JP6651506B2 (https=) |
| AU (1) | AU2015308773B2 (https=) |
| ES (1) | ES2872537T3 (https=) |
| WO (1) | WO2016033444A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2843684A1 (en) * | 2010-08-13 | 2012-02-16 | Tufts University | Compositions, kits and methods for treatment of macular degeneration using soluble membrane-independent cd59 protein |
| EP3892291A1 (en) | 2014-08-28 | 2021-10-13 | Tufts University | Compositions, methods and kits for treating complement related disorders |
| GB201608046D0 (en) * | 2016-05-09 | 2016-06-22 | Cambridge Entpr Ltd And Syndey Children S Hospitals Network Randwick And Westmead Incorporating The | Treatment of complement-mediated disorders |
| JP2020505472A (ja) * | 2017-01-27 | 2020-02-20 | ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティ アンド アグリカルチュアル アンド メカニカル カレッジ | 自己免疫性糖尿病のための二官能性低分子ペプチド |
| CN109331186B (zh) * | 2018-10-10 | 2022-04-05 | 华南师范大学 | 一种脂质体修饰的金纳米粒复合物及其在治疗帕金森氏症方面的应用 |
| US20220195012A1 (en) * | 2019-04-13 | 2022-06-23 | National Centre For Cell Science | Daf-mcp chimeric proteins, process to manufacture the same and use of the chimeric protein for treating pathological conditions involving the complement system |
| JP2024525183A (ja) * | 2021-06-18 | 2024-07-10 | イカロベック リミテッド | 網膜障害 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4405712A (en) | 1981-07-01 | 1983-09-20 | The United States Of America As Represented By The Department Of Health And Human Services | LTR-Vectors |
| US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
| AU4404785A (en) | 1984-05-25 | 1985-12-31 | Dana-Farber Cancer Institute, Inc. | Ltr vectors, methods of preparation and use |
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US4861719A (en) | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
| US4980289A (en) | 1987-04-27 | 1990-12-25 | Wisconsin Alumni Research Foundation | Promoter deficient retroviral vector |
| CA1315719C (en) | 1988-02-05 | 1993-04-06 | Arthur Bank | Retroviral packaging cell lines and processes of using same |
| US5112767A (en) | 1988-03-04 | 1992-05-12 | University Of Southern California | Vectors with enhancer domains |
| WO1990002806A1 (en) | 1988-09-01 | 1990-03-22 | Whitehead Institute For Biomedical Research | Recombinant retroviruses with amphotropic and ecotropic host ranges |
| WO1990002797A1 (en) | 1988-09-15 | 1990-03-22 | North Carolina State University | Self-inactivating, replication defective, retroviral vectors and helper cells for producing the same |
| US5124263A (en) | 1989-01-12 | 1992-06-23 | Wisconsin Alumni Research Foundation | Recombination resistant retroviral helper cell and products produced thereby |
| WO1990013641A1 (en) | 1989-05-10 | 1990-11-15 | Sloan-Kettering Institute For Cancer Research | Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
| EP0854193A1 (en) | 1990-09-21 | 1998-07-22 | Chiron Corporation | Human retroviral packaging cell line |
| ES2096750T3 (es) | 1990-10-31 | 1997-03-16 | Somatix Therapy Corp | Vectores retroviricos utiles para la terapia genica. |
| US5122767A (en) | 1991-01-10 | 1992-06-16 | Northern Telecom Limited | Saw device tapped delay lines |
| DE69131908T3 (de) | 1991-02-19 | 2008-04-03 | Oxford Biomedica (Uk) Ltd. | Viruspartikel mit veraendertem wirtspektrum |
| AU3434393A (en) | 1992-01-17 | 1993-08-03 | Regents Of The University Of Michigan, The | Targeted virus |
| US5627264A (en) | 1994-03-03 | 1997-05-06 | Alexion Pharmaceuticals, Inc. | Chimeric complement inhibitor proteins |
| US5851826A (en) | 1995-07-26 | 1998-12-22 | Children's Medical Center Corporation | Helper virus-free herpesvirus vector packaging system |
| US5843884A (en) | 1995-11-15 | 1998-12-01 | Oklahoma Medical Research Foundation | C9 complement inhibitor |
| US7166568B1 (en) | 1998-02-09 | 2007-01-23 | Oklahoma Medical Research Foundation | Compositions and methods to inhibit formation of the C5b-9 complex of complement |
| US6689600B1 (en) | 1998-11-16 | 2004-02-10 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
| ES2478820T3 (es) * | 2008-02-15 | 2014-07-23 | Tufts University | Tratamiento de degeneración macular |
| WO2012016162A2 (en) * | 2010-07-29 | 2012-02-02 | Tufts University | Compositions, methods and kits for modeling, diagnosing, and treating complement disorders |
| US8877896B2 (en) | 2008-02-15 | 2014-11-04 | Tufts University | Compositions, methods and kits for modeling, diagnosing, and treating complement disorders |
| HK1218300A1 (zh) * | 2013-01-23 | 2017-02-10 | Musc Foundation For Research Development | 基於天然抗體的靶向結構體及其應用 |
| US9617940B2 (en) | 2014-08-14 | 2017-04-11 | General Electric Company | Engine diagnostic system and an associated method thereof |
| EP3892291A1 (en) | 2014-08-28 | 2021-10-13 | Tufts University | Compositions, methods and kits for treating complement related disorders |
-
2015
- 2015-08-28 EP EP21161633.9A patent/EP3892291A1/en active Pending
- 2015-08-28 ES ES15836880T patent/ES2872537T3/es active Active
- 2015-08-28 EP EP15836880.3A patent/EP3186269B1/en active Active
- 2015-08-28 AU AU2015308773A patent/AU2015308773B2/en active Active
- 2015-08-28 WO PCT/US2015/047405 patent/WO2016033444A1/en not_active Ceased
- 2015-08-28 JP JP2017511190A patent/JP6651506B2/ja active Active
-
2017
- 2017-02-28 US US15/444,500 patent/US10813977B2/en active Active
-
2019
- 2019-10-10 JP JP2019186857A patent/JP6811821B2/ja active Active
-
2020
- 2020-10-09 US US17/067,515 patent/US11654179B2/en active Active
- 2020-12-15 JP JP2020207487A patent/JP7275095B2/ja active Active
-
2023
- 2023-05-19 US US18/199,616 patent/US20230414714A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020019813A5 (https=) | ||
| CN111217918B (zh) | 一种基于2,4-二氧四氢喋啶合酶的新型冠状病毒s蛋白双区域亚单位纳米疫苗 | |
| JP6811821B2 (ja) | 補体関連障害を処置するための組成物、方法およびキット | |
| JP2017527558A5 (https=) | ||
| JP2015505299A5 (https=) | ||
| CN113173995B (zh) | 一种结合冠状病毒的双特异性抗体 | |
| JP2016533332A5 (https=) | ||
| CN113527510A (zh) | 融合蛋白分子及其制备方法和用途 | |
| JP2008508885A5 (https=) | ||
| JP2020534865A5 (https=) | ||
| JP2000516098A (ja) | 短シャフトアデノウイルスファイバーおよびその用途 | |
| CN108350462A (zh) | 嵌合抗原受体及其用途 | |
| US8932601B2 (en) | Hybrid and chimeric polypeptides that regulate activation of complement | |
| CN112194726B (zh) | 用于病理性蛋白聚集物清除的嵌合抗原受体及其应用 | |
| JP2017537888A5 (https=) | ||
| WO2017059819A1 (zh) | 高亲和力的可溶性pdl-1分子 | |
| JP4080423B2 (ja) | アデノウイルスタンパク質ｉｘ、ならびにキャプシドアセンブリー、転写活性および核再組織化に関与するそのドメイン | |
| WO2023179548A1 (zh) | 纳米抗体s43的构建体及其应用 | |
| WO2021174567A1 (zh) | 一种基于细菌复合物的新型冠状病毒s蛋白双区域亚单位纳米疫苗 | |
| CN107880117A (zh) | 识别人乙型肝炎病毒x蛋白的单克隆抗体及用途 | |
| TWI508973B (zh) | 親和力成熟之ＣＲＩｇ變體 | |
| CN107502612A (zh) | 一种识别结合WSSV的层粘连蛋白受体基因Cq‑LR及其制备方法与应用 | |
| JP2011115077A5 (https=) | ||
| JPWO2020027010A5 (https=) | ||
| JP2011519950A5 (https=) |